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Abstract Ceramides which arise in part from the breakdown of
sphingomyelin comprise a class of antiproliferative lipids and
have been implicated in the regulation of programmed cell death
better known as apoptosis. In the present study, two new
synthetic ceramide analogues, N-thioacetylsphingosine and FS-5,
were used in Molt 4 cells to induce cell death. Besides their
cytotoxic effects at concentrations v14 WM the data obtained
clearly show that both analogues induced apoptosis at concen-
trations below this critical concentration as assessed by trypan
blue exclusion and cleavage of the death substrate poly-(ADP-
ribose) polymerase (PARP). Additional experiments in bcl-2-
transfected Molt 4 cells revealed that the apoptotic but not the
lytic effects of the analogues were antagonized by the apoptosis
inhibitor Bcl-2. Furthermore, neither N-thio-acetylsphingosine
nor FS-5 induced PARP cleavage in bcl-2-transfected Molt 4
cells indicating that the induction of apoptotic cell death by cell
permeable ceramides is not due to unspecific disturbance of the
cell membrane.
z 1997 Federation of European Biochemical Societies.
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1. Introduction
Sphingolipids are well known structural components of the
lipid bilayer of eukaryotic cell membranes. During the last few
years, it has become increasingly obvious in di¡erent cell types
that one member of this lipid class, sphingomyelin (SM), takes
part in a novel pathway of cell signalling [1^5], and the term
SM cycle has been coined for characterizing this function.
1K,25-Dihydroxyvitamin D
3
was the ¢rst compound identi¢ed
as an inducer of SM hydrolysis in HL-60 human leukemia
cells leading to the generation of intracellular ceramide [1].
Using cell-permeable ceramide analogues, it was possible to
mimick the e¡ects of 1K,25-dihydroxyvitamin D
3
on cell pro-
liferation thereby con¢rming ceramide to be an important
mediator of 1K,25-dihydroxyvitamin D
3
-induced HL-60 cell
di¡erentiation [6]. In contrast to the mitogenic lipid mediator
diacylglycerol (DAG) that arises from the hydrolysis of di¡er-
ent glycerophospholipids [7,8] ceramide was described as a
mediator of growth suppression and apoptosis [9].
Apoptosis, or programmed cell death, is a form of physio-
logical cell death which can be distinguished from accidental
destruction, or necrosis (for review, see [10]). Necrotic cell
death occurs when a cell is severely injured, for example by
a harsh physical insult, the cell begins to swell and the plasma
membrane ruptures. On the other hand, cells undergoing
apoptosis shrink and pull away from its neighbors. In apop-
totic cells the plasma membrane remains intact and the chro-
matin frequently breaks into fragments that produce a ladder-
like pattern. Recent experimental observations revealed that
intracellular proteases might play a critical role in the initia-
tion of apoptosis and the speci¢c proteolytic cleavage of cel-
lular proteins, such as poly-(ADP ribose) polymerase (PARP),
has been identi¢ed during apoptosis in a wide variety of cells
(for reviews, see [11,12]). Cleavage of PARP is catalyzed by a
zymogen called Yama/CPP32L and leads to inactivation of
this enzyme and generation of a 85 kDa apoptotic fragment
[13]. Since ceramide was implicated in apoptotic cell death it is
interesting that induction of the SM cycle or treatment of cells
with cell-permeable ceramides also led to the cleavage of
PARP and that this induction of PARP-cleavage was inhib-
ited in bcl-2-transfected cells [14].
In the present study, the e¡ects of two newly synthesized
ceramide analogues, N-thio-acetylsphingosine (C
2
-CerNS)
and FS-5 (for chemical structures, see Fig. 1), on the induc-
tion of apoptotic cell death and PARP-cleavage were inves-
tigated in Molt 4 and bcl-2-transfected Molt 4 cells. The re-
sults showed that treatment of Molt 4 cells with 11.2 WM C
2
-
CerNS and 11.2^56.2 WM FS-5 induced cell death and cleav-
age of PARP after 13 h of incubation. Further experiments
demonstrated that PARP-proteolysis was totally abolished in
bcl-2-transfected Molt 4 cells.
2. Materials and methods
2.1. Materials
Polyclonal anti-PARP antibodies were a kind gift from Dr. Guy
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Poirier (Quebec, Canada). DAG kinase was prepared as described
[14,15]. Silica gel 60 TLC plates, solvents and reagents were from
Whatman (Maidstone, UK). The ECL immunoblotting detection re-
agent was from Amersham (Cleveland, OH). [Q-
32
P]ATP (110 TBq/
mmol) was obtained from NEN-DuPont (Bad Homburg, Germany).
Hygromycin B was from Calbiochem (San Diego, CA). Trypan blue
solution (0.4%) was from Sigma (St. Louis, MO). C
2
-CerNO was
synthesized as described [16]. C
2
-CerNO, C
2
-CerNS and FS-5 stock
solutions were prepared in ethanol at concentrations of 10.0 mM, 28.0
mM and 28.1 mM, respectively. The purity of the used ceramide
analogues was assessed by high-performance TLC using the solvent
system chloroform/methanol (9:1, v/v) and compared with commer-
cially available C
2
-CerNO (Alexis, La
ë
ufel¢ngen, Switzerland). In all
cases the purity of the analogues was s 98%. Ethanol (vehicle) was
added to controls and was present at 0.2% or less in the experiments.
2.2. Synthesis of C
2
-CerNS and FS-5
C
2
-CerNS was synthesized from sphingosine and methyl dithioace-
tate [17,18]. The reaction product was fully characterized by NMR-
spectroscopy and FAB MS. The detailed synthesis will be published
elsewhere together with the preparation of additional analogues.
FS-5 (4-dodecanoylamino-decan-5-ol) was synthesized starting from
1-nitrobutane and n-hexanal according to [19], followed by acylation
with dodecanoic acid. FS-5 was characterized by
1
H-NMR-spectros-
copy and high-resolution MS.
2.3. Cell culture
Human leukemia Molt 4 vector control cells and a bcl-2-transfected
clone [15] were grown in RPMI selection medium supplemented with
10% heat-inactivated fetal calf serum (FCS) and 250 Wg/ml hygro-
mycin B. For the experiments, vector control cells were used between
passages 52 and 69, and bcl-2-transfected cells between passages 60
and 66.
2.4. Cytotoxicity assay
For this, Molt 4 vector control and bcl-2-transfected cells were
seeded at a density of 5U10
5
cells/ml in RPMI medium supplemented
with 2% FCS. The cells were equilibrated at 37³C for 30 min and then
treated with di¡erent concentrations of C
2
-CerNS and FS-5. In these
experiments, C
2
-CerNO and ethanol were used as positive and neg-
ative controls. After 6 and 13 h of incubation, 100 Wl of a trypan blue
solution (0.4%) were added to 500 Wl cell suspension and blue (dead)
and unstained (living) cells were counted in a hemacytometer as de-
scribed previously [20].
2.5. Determination of PARP cleavage
Cleavage of the death substrate PARP was determined as described
by Tewari et al. [13]. For this, Molt 4 vector control and bcl-2-trans-
fected cells were seeded at a density of 5U10
5
cells/ml in RPMI
medium supplemented with 2% FCS. The cells were equilibrated at
37³C for 30 min and then treated with di¡erent concentrations of C
2
-
CerNS and FS-5. In these experiments, C
2
-CerNO and ethanol were
used as positive and negative controls. After 6 and 13 h of incubation,
1 ml of each cell suspension was transferred to a reaction tube and the
samples were centrifuged at 350Ug, 4³C for 5 min. The supernatants
were discarded and 20 Wl reducing SDS sample bu¡er were added to
the cell pellets. Proteins were separated by 6% SDS-PAGE [21] and
transferred to nitrocellulose membrane. Then, PARP and the 85 kDa
fragment of PARP were detected with a polyclonal rabbit anti-PARP
antibody (1:2000) and the ECL immunoblotting detection kit from
Amersham was used to visualize the proteins in question [22].
2.6. Determination of cellular ceramide
The ceramide assay was carried out by the method of Preiss et al.
[23] using DAG kinase as described previously [24] with some mod-
i¢cations to simultaneously determine ceramide and diacylglycerol in
the samples. In detail, Molt 4 vector control cells were seeded at a
density of 5U10
5
cells/ml in RPMI containing 2% FCS and equili-
brated at 37³C for 30 min. Then, cells were treated for 3 and 5 h with
20 WM etoposide, 11.2 WM C
2
-CerNS, 11.2 WM FS-5 or 0.2% ethanol.
After incubation, cells were collected in a Beckmann CS-6 centrifuge
at 1000 rpm for 5 min and lipids were extracted according to Bligh
and Dyer [25]. The chloroform phase was transferred to glass tubes,
dried under nitrogen and redissolved in 1 ml of chloroform/methanol
(9:1, v/v). Subsequently, 800 Wl were taken for ceramide measure-
ments and 200 Wl were taken for the determination of phospholipids
by the phosphate assay of Ames and Dubin using ammonium molyb-
date and ascorbic acid [26]. For ceramide measurements, the dried
lipid extract was solubilized in 20 Wl of a detergent solution containing
7.5% octyl-L-D-glucoside and 25 mM dioleoyl phosphatidylglycerol in
1 mM diethylenetriaminepentaacetic acid (DETAPAc) by sonication.
70 Wl of assay bu¡er containing 0.1 M imidazole-HCl, pH 6.6, 0.1 M
NaCl, 25 mM MgCl
2
, 2 mM [ethylene-bis(oxyethylenenitrilo)] tetra-
acetic acid (EGTA), 3 mM dithiothreitol and 5 Wg sn1,2-DAG kinase
from E. coli was added. The reaction was started by addition of 10 Wl
of a 2.5 mM [Q-
32
P]ATP solution (116 000 dpm/nmol) in 0.1 M imi-
dazole-HCl, pH 6.6, containing 1 mM DETAPAc. After incubation at
20³C for 30 min, the reaction was stopped by adding 2 ml of meth-
anol, 1 ml of chloroform and 0.7 ml of water. The samples were
stirred on a vortex mixer and phase separation was accomplished
by addition of 1 ml of chloroform and 1 ml of water. After centrifu-
gation, the upper phase was aspirated and 1.5 ml of the lower phase
were transferred to another tube. The samples were dried under nitro-
gen and redissolved in 100 Wl of chloroform/methanol (9:1, v/v).
Then, 20 Wl of each sample were spotted on silica gel 60 TLC plates.
Plates were developed with chloroform/acetone/methanol/acetic acid/
water (50:20:15:10:5, v/v) and subjected to autoradiography. Marked
spots co-chromatographing with ceramide phosphate standards were
scraped into scintillation vials and radioactivity in the silica gel scrap-
ings was determined by liquid scintillation spectrometry. The amount
of ceramide present in the samples was calculated from the sample
volume and a ceramide standard curve. Determination of ceramide
was linear over the range 20^640 pmol.
2.7. Other procedures
Statistical comparisons were made in these studies with Student's
t-test.
3. Results and discussion
3.1. Cytotoxic e¡ects of C
2
-CerNS and FS-5 in Molt 4 cells
One possible mechanism mediating the biological properties
of ceramide analogues might be a simple toxic e¡ect, e.g.
cellular lysis or unspeci¢c disturbance of cellular membranes
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Fig. 1. Chemical structures of C
2
-CerNO, C
2
-CerNS and FS-5.
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as has been described at high concentrations of the synthetic
sphingolipid, N-acetyl-erythro-sphingosine-1-phosphocholine
[20]. On the other hand, elevation of intracellular ceramide
levels has been observed in many di¡erent forms of apoptosis
and treatment of cells with truncated ceramide analogues was
su¤cient to induce apoptosis [27]. In our experimental system,
FS-5 did not have an e¡ect on viability after 6 h of incubation
whereas C
2
-CerNS showed acute toxic e¡ects with a LD
50
of
28.0 WM (Fig. 2A, insert). At longer incubation periods of 13
h, the cytotoxic e¡ect of C
2
-CerNS was even more pro-
nounced (LD
50
=22.4 WM) and incubation of Molt 4 vector
control cells with 56.2 WM FS-5 signi¢cantly decreased viabil-
ity to about 70% of control (Fig. 2A). As compared with the
well known ceramide analogue, N-acetylsphingosine (C
2
-Cer-
NO) which decreased viability of Molt 4 cells to 11þ 7% at
23.4 WM, C
2
-CerNS had a cytotoxic capacity of approx-
imately 61% and FS-5 of 24%. These experiments revealed
that both ceramide analogues are biologically active com-
pounds in Molt 4 cells.
3.2. Induction of PARP cleavage by C
2
-CerNS and FS-5
in Molt 4 cells
Recently, it has been demonstrated that treatment of cells
with truncated ceramides led to the proteolytic cleavage of the
death substrate PARP [14] (see also Fig. 3). Therefore, the
induction of PARP cleavage upon treatment with C
2
-CerNS
and FS-5 was investigated in Molt 4 cells. As shown in Fig. 3,
a weak signal of the 85 kDa fragment of PARP is seen after
6 h of incubation with 11.2 WM C
2
-CerNS and 11.2^56.2 WM
FS-5 when the cell lysates were analyzed by Western blot.
After 13 h of incubation, the 85 kDa fragment accumulated
in C
2
-CerNS- and FS-5-treated cells thereby con¢rming that
the cells were driven into apoptosis. In support of the data on
viability described in the previous section only concentrations
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Fig. 2. Cytotoxicity of C
2
-CerNS and FS-5 in vector control and bcl-2 transfected Molt 4 cells. 5U10
5
vector control cells (A) and bcl-2-trans-
fected cells (B) were treated with di¡erent concentrations of C
2
-CerNS (E) and FS-5 (a). After 6 h (insert) or 13 h, viability of the cells was
determined by trypan blue exclusion as described in Section 2. Values are given in % of controlþ SD (n=4).
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6 14 WM C
2
-CerNS induced PARP-cleavage whereas the 85
kDa fragment was not observed in cells treated with C
2
-
CerNS concentrations of 28.0 and 55.9 WM (Fig. 3). In addi-
tional experiments, we used C
2
-CerNS concentrations below
28.0 WM, and 11.2 WM was found to be the optimum concen-
tration (data not shown). In contrast, FS-5 showed concen-
tration-dependent e¡ects on PARP-cleavage and 56.2 WM FS-
5 was the most e¤cient concentration used. Interestingly, it
was reported that only ceramides containing a 4,5-trans-dou-
ble bond induce apoptosis [16]. Thus, FS-5 is the ¢rst com-
pound with pro-apoptotic properties lacking this structural
feature.
3.3. E¡ects of C
2
-CerNS and FS-5 on endogeneous ceramide
levels in Molt 4 cells
Generation of ceramides has been reported as a common
cellular response of di¡erent cell types after challenge with
death-inducing agents, such as TNFK [28,29], interleukin-1L
[30], ionizing radiation [31] and therapeutic agents, such as
retinoic acid [3] and 1K,25-dihydroxyvitamin D
3
[32]. To ex-
clude the possibility that the induction of PARP-cleavage by
C
2
-CerNS and FS-5 is indirectly mediated by an increase in
endogeneous ceramide levels, cellular ceramide was measured
in extracts from Molt 4 cells which had been treated with 11.2
WM of the respective ceramide analogue for 3 and 5 h using
DAG kinase. However, neither C
2
-CerNS nor FS-5 signi¢-
cantly increased ceramide levels in Molt 4 cells (Table 1).
3.4. Bcl-2 antagonizes C
2
-CerNS- and FS-5-induced
cytotoxicity and PARP cleavage
The apoptosis inhibitors Bcl-2 and Bcl-XL have been
shown to block ceramide-induced cell death in lymphoid cell
lines [14,27,33,34]. To study the speci¢city of C
2
-CerNS and
FS-5-induced cell death we used Molt 4 cells which had been
transfected with bcl-2. As shown in Fig. 2B, bcl-2-transfected
Molt 4 cells were less sensitive to treatment with C
2
-CerNS
and FS-5. In the case of FS-5 the cytotoxic e¡ect occurring
after 13 h in control vector cells was totally blocked in bcl-2-
transfected cells. On the other hand, only the cytotoxic e¡ect
induced by 14.0 WM C
2
-CerNS was antagonized in bcl-2-
transfected cells whereas 28.0 and 55.9 WM C
2
-CerNS still
killed the cells (Fig. 2B). This failure of anti-apoptotic pro-
teins, such as Bcl-XL, to block the cytotoxic e¡ect of trun-
cated ceramides at high concentrations has also been observed
in endothelial cells [34]. Further experiments revealed that C
2
-
CerNS and FS-5-induced cleavage of PARP was totally abol-
ished in bcl-2-transfected Molt 4 cells (Fig. 4) suggesting that
overexpression of Bcl-2 interrupts the pro-apoptotic e¡ects of
both ceramide analogues. Since it was shown previously that
bcl-2-transfection did not interfere with ceramide-production
via the sphingomyelin cycle [15] these data are consistent with
the hypothesis that Bcl-2 acts downstream of ceramide for-
mation.
In summary, we provide data about two newly synthesized
ceramide analogues with di¡erent biological activities. The
sulfur-containing C
2
-CerNS induced apoptotic cell death at
low concentrations as shown by PARP-cleavage. However, at
FEBS 18865 12-9-97
Table 1
E¡ects of etoposide, C
2
-CerNS and FS-5 on endogenous ceramide
levels in Molt 4 cells
Treatment Ceramide (% of control)
Incubation
(3 h) (5 h)
Control 100þ 5 100þ 1320
WM etoposide 95þ 23 149þ 6

11.2 WM C
2
-CerNS 88þ 30 113þ 18
11.2 WM FS-5 98þ 21 104þ 16
Molt 4 vector control cells were incubated for 3 and 5 h in medium
containing 20 WM etoposide, 11.2 WM C
2
-CerNS, 11.2 WM FS-5 or
0.2% EtOH as control. After treatment, cells were collected and ce-
ramide and lipid phosphate were analyzed as described in Section 2.
Values of endogenous ceramide are given in % of control þSD (n=3).
Ceramide levels in control cells were 4.0þ 1.1 pmol/nmol phosphate.

Signi¢cantly di¡erent from controls at P6 0.01.
Fig. 3. Induction of PARP cleavage by C
2
-CerNS and FS-5 in Molt 4 cells. 5U10
5
vector control cells were treated with 11.7 WM C
2
-CerNO
or with di¡erent concentrations of C
2
-CerNS or FS-5. After 6 h and 13 h of incubation, cleavage of the death substrate PARP was assessed
by Western blot analysis as described in Section 2. The experiment was repeated and similar results were obtained.
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concentrations v28.0 WM the cell ghost-like morphology of
the cells indicated membrane damage and the cytotoxic e¡ects
of C
2
-CerNS were no longer accompanied by an induction of
PARP-cleavage and not inhibited by Bcl-2 thereby suggesting
cell lysis. On the other hand, the ceramide analogue FS-5
which is blocked at the C1-position of the sphingosine back-
bone speci¢cally induced apoptosis at concentrations 956.2
WM. From these data, we suggest that the concept of using
synthetic ceramide analogues may lead to signi¢cant insights
into ceramide-mediated signalling.
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Fig. 4. Inhibition of C
2
-CerNS- and FS-5-induced PARP cleavage in bcl-2 transfected Molt 4 cells. 5U10
5
bcl-2-transfected cells were treated
with 11.7 WM C
2
-CerNO or with di¡erent concentrations of C
2
-CerNS or FS-5. Additionally, vector control cells that had been treated with
11.7 WM C
2
-CerNO were used as positive controls. After 6 h and 13 h of incubation, cleavage of the death substrate PARP was assessed by
Western blot analysis as described in Section 2. The experiment was repeated and similar results were obtained.
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